3.0 Selection of Patients 
Patients will be carefully selected based on 
consideration of their past medical history and present status. 
The referring physician, the attending physician, and infectious 
disease or the relevant clinical department, the patient, and 
family members will make a joint decision regarding the inclusion 
of the patient in this trial. The following criteria will be 
used to select appropriate patients for study: 
3.1 Criteria for patient eligibility 
3.1.1 Patient must be HIV seropositive. 
3.1.2 Patient must be greater than 18 years of age. 
3.1.3 The patients must be treated with AZT. 
3.1.4 Patient must have a CD4 count greater than 
250. 
3.1.5 The patient must be able to provide informed 
consent. 
3.2 Criteria for patient ineligibility 
3.2.1 Patients with active autoimmune disease. 
3.2.2 Patients with an acute infectious illness 
within one month of initiation of treatment. 
3.2.3 Patients with active hepatitis, chronic or 
acute. 
3.2.4 Patients with diabetes mellitis who are not 
controlled by medical treatment. 
3.2.5 Psychiatric illness which makes compliance to 
the clinical protocol unmanageable. 
3.2.6 Patients on high dose glucocorticosteroids . 
[121 
Recombinant DNA Research, Volume 18 
